Determination of molindone enantiomers in human plasma by high-performance liquid chromatography–tandem mass spectrometry using macrocyclic antibiotic chiral stationary phases

High-Performance Liquid Chromatography Enantioseparations Using Macrocyclic Glycopeptide-Based Chiral Stationary Phases: An Overview

Since their introduction by Daniel W. Armstrong in 1994, antibiotic-based chiral stationary phases have proven their applicability for the chiral resolution of various types of racemates. The unique structure of macrocyclic glycopeptides and their large variety of interactive sites (e.g., hydrophobic pockets, hydroxy, amino and carboxyl groups, halogen atoms, aromatic moieties) are the reasons for their wide-ranging selectivity. The commercially available Chirobiotic™ phases, which display complementary characteristics, are capable of separating a broad variety of enantiomeric compounds with good efficiency, good column loadability, high reproducibility, and long-term stability. These are the major reasons for the frequent use of macrocyclic antibiotic-based stationary phases in HPLC enantioseparations.This overview chapter provides a brief summary of general aspects of antibiotic-based chiral stationary phases including their preparation and their application to direct enantioseparations of various racemates focusing on the literature published since 2004.

Fabrication of cefotaxime sodium-functionalized gold nanoclusters for the detection of copper ions in Chinese herbal medicines

Antibiotic-based gold nanoclusters (AuNCs) are a good sensing platform for specific recognition; however, the related studies are few. Herein, a simple and facile strategy was proposed for the fabrication of bright blue fluorescent AuNCs through the degradation product (DCTX) of cefotaxime sodium that induced the reduction of HAuCl₄. Various analytical techniques were applied to characterize the prepared AuNCs@DCTX. AuNCs@DCTX exhibited a strong emission peak centered at 420 nm and a quantum yield of 11.8%. Furthermore, an aggregation-induced fluorescence quenching mode endowed the AuNCs@DCTX probe with good specificity and sensitivity for Cu²⁺ detection. The proposed probe had a linear range of 0.01–40 μM, a precision with a relative standard deviation of 1.2% (n = 8), and a detection limit of 8 nM (signal/noise = 3). Interestingly, the probe could be reused through switching the “off” and “on” states by the addition of Cu²⁺ and EDTA. The practicality of the sensing platform was investigated for the determination of Cu²⁺ in four Chinese herbal medicines (CHMs), and the results were in accordance with those obtained by the FAAS method. This study has provided an alternate way for the fabrication of thiolate-protected AuNCs for sensing applications.

Antibiotic-based gold nanoclusters (AuNCs) are a good sensing platform for specific recognition; however, the related studies are few.

Enantioseparations by high-performance liquid chromatography using macrocyclic glycopeptide-based chiral stationary phases: an overview

Since their introduction by Armstrong in 1994, macrocyclic antibiotic-based chiral stationary phases have proven their applicability for the chiral resolution of various types of racemates. The unique structure of macrocyclic glycopeptides and their large variety of interactive sites (e.g., hydrophobic pockets, hydroxyl, amino and carboxyl groups, halogen atoms, aromatic moieties, etc.) are the reason for their wide-ranging selectivity. The commercially available Chirobiotic™ phases, which display complementary characteristics, are capable of separating a broad variety of enantiomeric compounds with good efficiency, good column loadability, high reproducibility, and long-term stability. These are the major reasons for the use of macrocyclic antibiotic-based stationary phases in HPLC enantioseparations. This overview chapter provides a brief summary of general aspects of macrocyclic antibiotic-based chiral stationary phases including their preparation and their application to direct enantioseparations of various racemates focusing on the literature published since 2004.

Recent advances in bioanalytical sample preparation for LC-MS analysis

Sample preparation has historically been, and continues to be, the most challenging part of the bioanalytical workflow. Several techniques have been developed over the years to deal with the problems of recovery and matrix effects in an effort to increase the reliability and robustness of the bioanalytical method. In recent years certain techniques have come into prominence and gained acceptance in routine sample preparation, and some have shown promise in their use in a discovery environment where speed is critical and method development time is often limited. The aim of this review is to examine several of these techniques and provide examples of their use from the literature, as well as comment on their utility in current workflows.

Enantioselective quantification of chiral drugs in human plasma with LC–MS/MS

Today, approximately 60% of synthetic drugs are chiral and 88% of these chiral synthetic drugs are used therapeutically as racemates. However, for many racemic drugs, their stereospecific plasma pharmacokinetics in humans are not known due to the limitations of the analytical methods. Nowadays, liquid chromatography (LC)–tandem mass spectrometry (MS/MS) methods based on various chiral stationary phases (CSPs), with a high degree of specificity and sensitivity, have been widely used in enantioselective determination of chiral drugs and/or their metabolites in human plasma. The technologies and issues when coupling chiral chromatography with MS/MS detection in bioanalytical methods will be reviewed herein. The introduction and applications of various CPSs, including polysaccharide-, macrocyclic glycopeptide-, protein- and cyclodextrin-based phases, are described here. This review also includes a discussion of interface and matrix effects in enantioselective LC–MS/MS methods.